Skip to main content

Table 4 Acute (A) and late (B) non-hematologic toxicity (CTCAE,v 4.3), n = 100; n (%)

From: Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

  

Grade 1

Grade 2

Grade 3

Grade 4

Grade 5

A

Pneumonitis

n.a

12 (12)

2 (2)

 

Esophagitis

12 (12)

57 (57)

3 (3)

B

Bronchial stricture/Atelectasis

n.a

2 (2)

 

Hemorrhage

2 (2)

  1. CTCAE = Common Terminology Criteria for Adverse Effects; n.a. = not assessed